This is the seventh special EBMT report on the indications for haematopoietic stem cell
transplantation for haematological diseases, solid tumours and immune disorders. Our aim …

Acquired severe aplastic anemia (SAA) is a rare hematologic disease associated with
significant morbidity and mortality. Immune destruction of hemopoietic stem cells plays an …

For over two decades, the EBMT has updated recommendations on indications for
haematopoietic cell transplantation (HCT) practice based on clinical and scientific …

This is the sixth special report that the European Society for Blood and Marrow
Transplantation regularly publishes on the current practice and indications for …

Survival in severe aplastic anemia (SAA) has markedly improved in the past 4 decades
because of advances in hematopoietic stem cell transplantation, immunosuppressive …

Aplastic Anemia | New England Journal of Medicine Skip to main content The New England
Journal of Medicine homepage Advanced Search SEARCH The New England Journal of …

High-dose, posttransplantation cyclophosphamide (PTCy) reduces severe graft-versus-host
disease (GVHD) after allogeneic blood or marrow transplantation (alloBMT), but the impact …

Abstract Treatment options for newly diagnosed aplastic anemia (AA) patient includes
upfront allogeneic hematopoietic stem cell transplant (HSCT) or immunosuppressive …

Graft failure is a major complication after unrelated cord blood transplantation. Presence of
HLA-antibodies before cord blood transplantation may impact graft failure. To analyze the …

Optimal cord blood (CB) unit selection is critical to maximize the likelihood of successful
engraftment and survival after CB transplantation (CBT). However, unit selection can be …